Business

October 28, 2013 5:15 PM

Biogen Idec revenue up 32 percent in third quarter

Drugmaker Biogen Idec reported that sales of its new multiple sclerosis drug Tecfidera helped fuel a 32 percent jump in revenue in the third quarter.

Related content

Comments

Videos

Today's Market

Nasdaq
Powered by Barchart

Editor's Choice Videos

Raleigh Top Jobs

View All Top Jobs